CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
0.9601
-0.0182 (-1.86%)
At close: Dec 5, 2025, 4:00 PM EST
1.020
+0.060 (6.24%)
After-hours: Dec 5, 2025, 7:46 PM EST
CASI Pharmaceuticals Employees
CASI Pharmaceuticals had 233 employees as of December 31, 2024. The number of employees increased by 57 or 32.39% compared to the previous year.
Employees
233
Change (1Y)
57
Growth (1Y)
32.39%
Revenue / Employee
$115,219
Profits / Employee
-$211,953
Market Cap
19.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CASI News
- 17 days ago - CASI Pharmaceuticals Announces Changes in Board Governance - Accesswire
- 22 days ago - CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results - Accesswire
- 26 days ago - CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ - Accesswire
- 4 weeks ago - CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference - Accesswire
- 4 weeks ago - CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting - Accesswire
- 2 months ago - CASI Pharmaceuticals Appoints James Huang to Board of Directors - Accesswire
- 3 months ago - CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study - Accesswire
- 3 months ago - CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference - Accesswire